Additional file 1: of Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis

Additional file 1: of Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous

Carsten Nieder (75550)
Matthias Guckenberger (41734)
Laurie Gaspar (6370616)
Chad Rusthoven (6370619)
Dirk Ruysscher (6370622)
Arjun Sahgal (3772702)
Timothy Nguyen (1415479)
Anca Grosu (4637779)
Minesh Mehta (186572)

February 2019

Figure S1. Representative computed tomography and magnetic resonance imaging scans distributed to th...

Additional file 2: of Prophylactic cranial irradiation in small cell lung cancer: a systematic review and meta-analysis

Xin Yin (149454)
Danfang Yan (6248885)
Miao Qiu (6248888)
Liming Huang (110579)
Sen-Xiang Yan (6248891)

January 2019

Figure S1. The possibility of publication bias across studies was assessed using (a) funnel plots an...

Additional file 2: of Comparative efficacy of six therapies for Hypopharyngeal and laryngeal neoplasms: a network meta-analysis

Juan Che (6525440)
Yanlin Wang (110566)
Xiaolin Zhang (246784)
Jun Chen (4238)

March 2019

Table S2. Network meta-analysis results of subgroup analysis for locally advanced hypopharyngeal and...

Additional file 2: of Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients

Noman Paracha (3091284)
Ahmed Abdulla (497170)
Katherine MacGilchrist (5744387)

September 2018

Table S2. Listing of first-line mNSCLC studies with utility data excluded at second pass [80â100]....

Additional file 1: of Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis

Yixin Zhou (6113774)
Chen Chen (6544)
Xuanye Zhang (6113777)
Sha Fu (445944)
Cong Xue (285516)
Yuxiang Ma (522295)
Wenfeng Fang (172072)
Yunpeng Yang (522293)
Xue Hou (285519)
Yan Huang (46805)
Hongyun Zhao (285512)
Shaodong Hong (629679)
Li Zhang (8200)

December 2018

Supplementary Method. Search strategies for PubMed, EMBASE, and Cochrane database. (PDF 314 kb

Additional file 3 of Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis

Yixin Zhou (6113774)
Chen Chen (6544)
Xuanye Zhang (6113777)
Sha Fu (445944)
Cong Xue (285516)
Yuxiang Ma (522295)
Wenfeng Fang (172072)
Yunpeng Yang (522293)
Xue Hou (285519)
Yan Huang (46805)
Hongyun Zhao (285512)
Shaodong Hong (629679)
Li Zhang (8200)

December 2018

Table S1. Quality assessment: risk of bias by Cochrane Collaborationâs tool. Table S2. Additional ...

Additional file 7: of Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trials

Martin Connock (159426)
Xavier Armoiry (3413465)
Alexander Tsertsvadze (182148)
G. Melendez-Torres (3476636)
Pamela Royle (371969)
Lazaros Andronis (4038071)
Aileen Clarke (470453)

April 2019

Network meta-analysis estimating mean differences in restricted mean survival and overall survival (...

Additional file 2: Table S2. of Decision support systems for incurable non-small cell lung cancer: a systematic review

D. RĂŠvĂŠsz (4485874)
E. Engelhardt (4485871)
J. Tamminga (4485880)
F. Schramel (4485859)
B. Onwuteaka-Philipsen (4485868)
E. van de Garde (4485865)
E. Steyerberg (4485856)
E. Jansma (4485862)
H. De Vet (4485877)
V. CoupĂŠ (4485853)

October 2017

Overview and quality assessment of decision support systems for incurable patients with (initial or ...

Additional file 1 of Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review

Yimin Wang (724389)
Chuling Li (7466345)
Zimu Wang (10338749)
Zhaofeng Wang (1428373)
Ranpu Wu (14071903)
Ying Wu (19057)
Yong Song (286107)
Hongbing Liu (291584)

November 2022

Additional file 1: Fig. S1. A selection flowchart for the searched articles. Fig. S2. Forest plots p...

Additional file 8: of Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trials

Martin Connock (159426)
Xavier Armoiry (3413465)
Alexander Tsertsvadze (182148)
G. Melendez-Torres (3476636)
Pamela Royle (371969)
Lazaros Andronis (4038071)
Aileen Clarke (470453)

April 2019

Association of survival estimates and reported medians and hazard ratios. (DOCX 32 kb

Additional file 6: of Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trials

Martin Connock (159426)
Xavier Armoiry (3413465)
Alexander Tsertsvadze (182148)
G. Melendez-Torres (3476636)
Pamela Royle (371969)
Lazaros Andronis (4038071)
Aileen Clarke (470453)

April 2019

Forest plots of mean difference in RMS and mean difference in total survival (Weibull models). (DOCX...

Additional file 2 of Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis

Yixin Zhou (6113774)
Chen Chen (6544)
Xuanye Zhang (6113777)
Sha Fu (445944)
Cong Xue (285516)
Yuxiang Ma (522295)
Wenfeng Fang (172072)
Yunpeng Yang (522293)
Xue Hou (285519)
Yan Huang (46805)
Hongyun Zhao (285512)
Shaodong Hong (629679)
Li Zhang (8200)

December 2018

Figure S1. Trial selection process. Figure S2. Funnel plot comparing hazard ratios for (A) progressi...

Additional file 1: of First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy

Yixin Zhou (6113774)
Zuan Lin (6664979)
Xuanye Zhang (6113777)
Chen Chen (6544)
Hongyun Zhao (285512)
Shaodong Hong (629679)
Li Zhang (8200)

May 2019

Supplemental Methods. Search strategies and number of studies yielded from each database. Table S1. ...

Additional file 3: of Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials

Victor Huiskes (3661834)
David Burger (3661828)
Cornelia van den Ende (3661831)
Bartholomeus van den Bemt (3661837)

January 2017

Risk of bias assessment: sensitivity analysis. Sensitivity analysis regarding a more stringent cut-o...

Additional file 1: of The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: a systematic review and meta-analysis

Wen-Ya Li (6332414)
Ting-Ting Zhao (669831)
Hui-Mian Xu (5648992)
Zhen-Ning Wang (5648989)
Ying-Ying Xu (3838279)
Yunan Han (6332417)
Yong-Xi Song (5648986)
Jian-Hua Wu (6332420)
Hao Xu (6530)
Song-Cheng Yin (6332423)
Xing-Yu Liu (5949368)
Zhi-Feng Miao (6332426)

February 2019

Figure S1. meta-regression based on percentage of adenocarcinoma (P = 0.279). Figure S2. meta-regres...

Additional file 1: of Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous

Carsten Nieder (75550)
Matthias Guckenberger (41734)
Laurie Gaspar (6370616)
Chad Rusthoven (6370619)
Dirk Ruysscher (6370622)
Arjun Sahgal (3772702)
Timothy Nguyen (1415479)
Anca Grosu (4637779)
Minesh Mehta (186572)

February 2019

Figure S1. Representative computed tomography and magnetic resonance imaging scans distributed to th...

Additional file 2: of Prophylactic cranial irradiation in small cell lung cancer: a systematic review and meta-analysis

Xin Yin (149454)
Danfang Yan (6248885)
Miao Qiu (6248888)
Liming Huang (110579)
Sen-Xiang Yan (6248891)

January 2019

Figure S1. The possibility of publication bias across studies was assessed using (a) funnel plots an...

Additional file 2: of Comparative efficacy of six therapies for Hypopharyngeal and laryngeal neoplasms: a network meta-analysis

Juan Che (6525440)
Yanlin Wang (110566)
Xiaolin Zhang (246784)
Jun Chen (4238)

March 2019

Table S2. Network meta-analysis results of subgroup analysis for locally advanced hypopharyngeal and...

Additional file 2: of Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients

Noman Paracha (3091284)
Ahmed Abdulla (497170)
Katherine MacGilchrist (5744387)

September 2018

Table S2. Listing of first-line mNSCLC studies with utility data excluded at second pass [80â100]....

Additional file 1: of Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis

Yixin Zhou (6113774)
Chen Chen (6544)
Xuanye Zhang (6113777)
Sha Fu (445944)
Cong Xue (285516)
Yuxiang Ma (522295)
Wenfeng Fang (172072)
Yunpeng Yang (522293)
Xue Hou (285519)
Yan Huang (46805)
Hongyun Zhao (285512)
Shaodong Hong (629679)
Li Zhang (8200)

December 2018

Supplementary Method. Search strategies for PubMed, EMBASE, and Cochrane database. (PDF 314 kb

Additional file 3 of Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis

Yixin Zhou (6113774)
Chen Chen (6544)
Xuanye Zhang (6113777)
Sha Fu (445944)
Cong Xue (285516)
Yuxiang Ma (522295)
Wenfeng Fang (172072)
Yunpeng Yang (522293)
Xue Hou (285519)
Yan Huang (46805)
Hongyun Zhao (285512)
Shaodong Hong (629679)
Li Zhang (8200)

December 2018

Table S1. Quality assessment: risk of bias by Cochrane Collaborationâs tool. Table S2. Additional ...

Additional file 7: of Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trials

Martin Connock (159426)
Xavier Armoiry (3413465)
Alexander Tsertsvadze (182148)
G. Melendez-Torres (3476636)
Pamela Royle (371969)
Lazaros Andronis (4038071)
Aileen Clarke (470453)

April 2019

Network meta-analysis estimating mean differences in restricted mean survival and overall survival (...

Additional file 2: Table S2. of Decision support systems for incurable non-small cell lung cancer: a systematic review

D. RĂŠvĂŠsz (4485874)
E. Engelhardt (4485871)
J. Tamminga (4485880)
F. Schramel (4485859)
B. Onwuteaka-Philipsen (4485868)
E. van de Garde (4485865)
E. Steyerberg (4485856)
E. Jansma (4485862)
H. De Vet (4485877)
V. CoupĂŠ (4485853)

October 2017

Overview and quality assessment of decision support systems for incurable patients with (initial or ...

Additional file 1 of Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review

Yimin Wang (724389)
Chuling Li (7466345)
Zimu Wang (10338749)
Zhaofeng Wang (1428373)
Ranpu Wu (14071903)
Ying Wu (19057)
Yong Song (286107)
Hongbing Liu (291584)

November 2022

Additional file 1: Fig. S1. A selection flowchart for the searched articles. Fig. S2. Forest plots p...

Additional file 8: of Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trials

Martin Connock (159426)
Xavier Armoiry (3413465)
Alexander Tsertsvadze (182148)
G. Melendez-Torres (3476636)
Pamela Royle (371969)
Lazaros Andronis (4038071)
Aileen Clarke (470453)

April 2019

Association of survival estimates and reported medians and hazard ratios. (DOCX 32 kb

Additional file 6: of Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trials

Martin Connock (159426)
Xavier Armoiry (3413465)
Alexander Tsertsvadze (182148)
G. Melendez-Torres (3476636)
Pamela Royle (371969)
Lazaros Andronis (4038071)
Aileen Clarke (470453)

April 2019

Forest plots of mean difference in RMS and mean difference in total survival (Weibull models). (DOCX...

Additional file 2 of Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis

Yixin Zhou (6113774)
Chen Chen (6544)
Xuanye Zhang (6113777)
Sha Fu (445944)
Cong Xue (285516)
Yuxiang Ma (522295)
Wenfeng Fang (172072)
Yunpeng Yang (522293)
Xue Hou (285519)
Yan Huang (46805)
Hongyun Zhao (285512)
Shaodong Hong (629679)
Li Zhang (8200)

December 2018

Figure S1. Trial selection process. Figure S2. Funnel plot comparing hazard ratios for (A) progressi...

Additional file 1: of First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy

Yixin Zhou (6113774)
Zuan Lin (6664979)
Xuanye Zhang (6113777)
Chen Chen (6544)
Hongyun Zhao (285512)
Shaodong Hong (629679)
Li Zhang (8200)

May 2019

Supplemental Methods. Search strategies and number of studies yielded from each database. Table S1. ...

Additional file 3: of Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials

Victor Huiskes (3661834)
David Burger (3661828)
Cornelia van den Ende (3661831)
Bartholomeus van den Bemt (3661837)

January 2017

Risk of bias assessment: sensitivity analysis. Sensitivity analysis regarding a more stringent cut-o...

Additional file 1: of The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: a systematic review and meta-analysis

Wen-Ya Li (6332414)
Ting-Ting Zhao (669831)
Hui-Mian Xu (5648992)
Zhen-Ning Wang (5648989)
Ying-Ying Xu (3838279)
Yunan Han (6332417)
Yong-Xi Song (5648986)
Jian-Hua Wu (6332420)
Hao Xu (6530)
Song-Cheng Yin (6332423)
Xing-Yu Liu (5949368)
Zhi-Feng Miao (6332426)

February 2019

Figure S1. meta-regression based on percentage of adenocarcinoma (P = 0.279). Figure S2. meta-regres...

Additional file 1: of Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous

Carsten Nieder (75550)
Matthias Guckenberger (41734)
Laurie Gaspar (6370616)
Chad Rusthoven (6370619)
Dirk Ruysscher (6370622)
Arjun Sahgal (3772702)
Timothy Nguyen (1415479)
Anca Grosu (4637779)
Minesh Mehta (186572)

February 2019

Figure S1. Representative computed tomography and magnetic resonance imaging scans distributed to th...

Additional file 2: of Prophylactic cranial irradiation in small cell lung cancer: a systematic review and meta-analysis

Xin Yin (149454)
Danfang Yan (6248885)
Miao Qiu (6248888)
Liming Huang (110579)
Sen-Xiang Yan (6248891)

January 2019

Figure S1. The possibility of publication bias across studies was assessed using (a) funnel plots an...

Additional file 2: of Comparative efficacy of six therapies for Hypopharyngeal and laryngeal neoplasms: a network meta-analysis

Juan Che (6525440)
Yanlin Wang (110566)
Xiaolin Zhang (246784)
Jun Chen (4238)

March 2019

Table S2. Network meta-analysis results of subgroup analysis for locally advanced hypopharyngeal and...

Additional file 1: of Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis

Abstract

Extracted data

Additional file 1: of Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis

Abstract

Extracted data

Related items

Related items